Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer

Technology in Cancer Research and Treatment

Volumn 4, Issue 5, 2005, Pages 549-558

  Hsiang, David ^a   Shah, Natasha ^b   Yu, Hon ^a   Su, Min Ying ^a   Cerussi, Albert ^b   Butler, John ^a   Baick, Choong ^a   Mehta, Rita ^a   Nalcioglu, Orhan ^a   Tromberg, Bruce ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

And Coregistration; Breast tumors; Broadband spectroscopy; Diffuse optical spectroscopy; Dynamic contrast enhanced; Frequency domain photon migration; MRI; Near infrared; Photon migration; Tissue spectroscopy

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADULT; ARTICLE; BOLUS INJECTION; BREAST BIOPSY; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER SIZE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSE OPTICAL SPECTROSCOPY; FEMALE; HUMAN; IMAGE RECONSTRUCTION; INFLAMMATORY DISEASE; INTRADUCTAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON; SPECTROSCOPY;

EID: 26844525501     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460500400508     Document Type: Article

References (39)

1. N. Hylton. Magnetic Resonance Imaging of the Breast: Opportunities to Improve Breast Cancer Management. J. Clin. Oncol. 23, 1678-1684 (2005).
2. P. Ercolani, G. Valeri, and F. Amici. Dynamic MRI of the Breast. Eur. J. Radiol. 27 Suppl 2, S265-271 (1998).
3. S. H. Heywang-Kobrunner, P. Viehweg, A. Heinig, and C. Kuchler. Contrast-enhanced MRI of the Breast: Accuracy, Value, Controversies, Solutions. Eur. J. Radiol. 24, 94-108 (1997).
4. W. E. Reddick, R. Bhargava, J. S. Taylor, W. H. Meyer, and B. D. Fletcher. Dynamic Contrast-enhanced MR Imaging Evaluation of Osteosarcoma Response to Neoadjuvant Chemotherapy. J. Magn. Reson. Imaging. 5, 689-694 (1995).
5. D. F. Hayes, T. M. Walker, B. Singh, E. S. Vitetta, J. W. Uhr, S. Gross, C. Rao, G. V. Doyle, and L. W. Terstappen. Monitoring Expression of HER-2 on Circulating Epithelial Cells in Patients with Advanced Breast Cancer. Int. J. Oncol. 21, 1111-1117 (2002).
6. H. Hawighorst, W. Weikel, P. G. Knapstein, M. V. Knopp, I. Zuna, S. O. Schonberg, P. Vaupel, and G. van Kaick. Angiogenic Activity of Cervical Carcinoma: Assessment by Functional Magnetic Resonance Imaging-based Parameters and a Histomorphological Approach in Correlation with Disease Outcome. Clin. Cancer Res. 4, 2305-2312 (1998).
7. B. Bone, Z. Pentek, L. Perbeck, and B. Veress. Diagnostic Accuracy of Mammography and Contrast-enhanced MR Imaging in 238 Histologically Verified Breast Lesions. Acta. Radiol. 38, 489-496 (1997).
8. M. Kristoffersen Wiberg, P. Aspelin, L. Perbeck, and B. Bone. Value of MR Imaging in Clinical Evaluation of Breast Lesions. Acta. Radiol. 43, 275-281 (2002).
9. D. A. Bluemke, C. A. Gatsonis, M. H. Chen, G. A. DeAngelis, N. DeBruhl, S. Harms, S. H. Heywang-Kobrunner, N. Hylton, C. K. Kuhl, C. Lehman, E. D. Pisano, P. Causer, S. J. Schnitt, S. F. Smazal, C. B. Stelling, P. T. Weatherall, and M. D. Schnall. Magnetic Resonance Imaging of the Breast Prior to Biopsy. Jama 292, 2735-2742 (2004).
10. B.C. Wilson, M.S. Patterson, S. T. Flock, and D. R. Wyman. Tissue Optical Properties in Relation to Light Propagation Models and In Vivo Dosimetry. In Photon Migration in Tissues, pp. 25-42. Ed., B. Chance. New York: Plenum (1988).
11. S. Ertefai and A. E. Profio. Spectral Transmittance and Contrast in Breast Diaphanography. Medical Physics 12, 393-400, 1985).
12. E. M. Sevick, B. Change, J. Leigh, S. Nioka, and M. Maris. Quantitation of Time-resolved and Frequency-resolved Optical Spectra for the Determination of Tissue Oxygenation. Analytical Biochemistry 195, 330-351 (1991).
13. V. Quaresima, S. J. Matcher, and M. Ferrari. Identification and Quantification of Intrinsic Optical Contrast for Near-infrared Mammography. Photochemistry and Photobiology 67, 4-14 (1998).
14. J. R. Mourant, M. Canpolat, C. Brocker, O. Esponda-Ramos, T. M. Johnson, A. Matanock, K. Stetter, and J. P. Freyer. Light Scattering From Cells: The Contribution of the Nucleus and the Effects of Proliferative Status. J. Biomed. Opt. 5, 131-137 (2000).
15. S. L. Jacques. Origins of Tissue Optical Properties in the UVA, Visible, and NIR Regions (1996).
16. B. Beauvoit and B. Chance. Time-resolved Spectroscopy of Mitochondria, Cells and Tissues under Normal and Pathological Conditions. Molecular and Cellular Biochemistry 184, 445-455 (1998).
17. B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler. Non-invasive In Vivo Characterization of Breast Tumors Using Photon Migration Spectroscopy. Neoplasia 2, 26-40 (2000).
18. B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen. Quantitative Hemoglobin Tomography with Diffuse Near-infrared Spectroscopy: Pilot Results in the Breast. Radiology 218, 261-266 (2001).
19. E. L. Heffer and S. Fantini. Quantitative Oximetry of Breast Tumors: A Near-infrared Method that Identifies Two Optimal Wavelengths for Each Tumor. Appl. Opt. 41, 3827-3839 (2002).
20. P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu. Clinical Trial of Time-resolved Scanning Optical Mammography at 4 Wavelengths Between 683 and 975 nm. J. Biomed. Opt. 9, 464-473 (2004).
21. V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance. Concurrent MRI and Diffuse Optical Tomography of Breast After Indocyanine Green Enhancement. Proceedings of the National Academy of Sciences of the United States of America 97, 2767-2772 (2000).
22. S. Merritt, F. Bevilacqua, A. J. Durkin, D. J. Cuccia, R. Lanning, B. J. Tromberg, G. Gulsen, H. Yu, J. Wang, and O. Nalcioglu. Coregistration of Diffuse Optical Spectroscopy and Magnetic Resonance Imaging in a Rat Tumor Model. Appl. Opt. 42, 2951-2959 (2003).
23. S. Merritt, G. Gulsen, G. Chiou, Y. Chu, C. Deng, A. E. Cerussi, A. J. Durkin, B. J. Tromberg, and O. Nalcioglu. Comparison of Water and Lipid Content Measurements Using Diffuse Optical Spectroscopy and MRI in Emulsion Phantoms. Technol. Cancer Res. Treat. 2, 563-569 (2003).
24. J. G. Natasha Shah, D. Wolverton, A. Cerussi, N. Hylton, and B. Tromberg. Combined Diffuse Optical Spectroscopy and Contrast-enhanced MRI for Monitoring Breast Cancer Neoadjuvant Chemotherapy: A Case Study. Journal of Biomedical Optics In Press (2005).
25. B. Brooksby, S. Jiang, H. Dehghani, B. Pogue, K. Paulsen, C. Kogel, M. Doyley, J. Weaver, and S. Poplack. Magnetic Resonance-guided Near-infrared Tomography of the Breast. Review of Scientific Instruments 75, 5262-5270 (2004).
26. Y. Chen, D. R. Tailor, X. Intes, and B. Chance. Correlation Between Near-infrared Spectroscopy and Magnetic Resonance Imaging of Rat Brain Oxygénation Modulation. Phys. Med. Biol. 48, 417-427 (2003).
27. Y. Song, K. L. Worden, X. Jiang, D. Zhao, A. Constantinescu, H. Liu, and R. P. Mason. Tumor Oxygen Dynamics: Comparison of 19F MR EPI and Frequency Domain NIR Spectroscopy. Adv. Exp. Med. Biol. 530, 225-236 (2003).
28. H. E. D'Arceuil, M. P. Hotakainen, C. Liu, G. Themelis, A. J. de Crespigny, and M. A. Franceschini. Near-infrared Frequency-domain Optical Spectroscopy and Magnetic Resonance Imaging: A Combined Approach to Studying Cerebral Maturation in Neonatal Rabbits. J. Biomed. Opt. 10, 11011 (2005).
29. E. Gratton, V. Toronov, U. Wolf, M. Wolf, and A. Webb. Measurement of Brain Activity by Near-infrared Light. J. Biomed. Opt. 10, 11008 (2005).
30. H. Xu, R. Springett, H. Dehghani, B. W. Pogue, K. D. Paulsen, and J. F. Dunn. Magnetic-resonance-imaging-coupled Broadband Near-infrared Tomography System for Small Animal Brain Studies. Appl. Opt. 44, 2177-2188 (2005).
31. T. H. Pham, O. Coquoz, J. B. Fishkin, E. Anderson, and B. J. Tromberg. Broad Bandwidth Frequency Domain Instrument for Quantitative Tissue Optical Spectroscopy. Review of Scientific Instruments 71, 2500-2513 (2000).
32. D. B. Jakubowski, A. E. Cerussi, F. Bevilacqua, N. Shah, D. Hsiang, J. Butler, and B. J. Tromberg. Monitoring Neoadjuvant Chemotherapy in Breast Cancer Using Quantitative Diffuse Optical Spectroscopy: A Case Study. J. Biomed. Opt. 9, 230-238 (2004).
33. L. Esserman, E. Kaplan, S. Partridge, D. Tripathy, H. Rugo, J. Park, S. Hwang, H. Kuerer, D. Sudilovsky, Y. Lu, and N. Hylton. MRI Phenotype is Associated with Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer. Ann. Surg. Oncol. 8, 549-559 (2001).
34. S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Sudilovsky, and N. M. Hylton. Accuracy of MR Imaging for Revealing Residual Breast Cancer in Patients who have Undergone Neoadjuvant Chemotherapy. AJR Am. J. Roentgenol. 179, 1193-1199 (2002).
35. G. G. S. I. Merritt, A. E. Cerussi, Y. Chu, M. Hamamura, A. J. Durkin, O. Nalcioglu, and B. Tromberg. Correlation of Broadband Diffuse Optical Spectroscopy and Magnetic Resonance Imaging Signals in Muscle Tissue. Presented at BIOS, San Jose, CA (2005).
36. L. Harrison and K. Blackwell. Hypoxia and Anemia: Factors in Decreased Sensitivity to Radiation Therapy and Chemotherapy? Oncologist 9 Suppl 5, 31-40 (2004).
37. A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey. Tumour Hypoxia, Chemotherapeutic Resistance and Hypoxia-related Therapies. Cancer Treat. Rev. 29, 297-307 (2003).
38. R. H. Pin, M. Reinblatt, and Y. Fong. Employing Tumor Hypoxia to Enhance Oncolytic Viral Therapy in Breast Cancer. Surgery 136, 199-204 (2004).
39. Y. Song, A. Constantinescu, and R. P. Mason. Dynamic Breast Tumor Oximetry: The Development of Prognostic Radiology. Technol. Cancer Res. Treat. 1, 471-478 (2002).